Skip to main content
. 2015 Nov 2;20(11):19735–19747. doi: 10.3390/molecules201119653

Table 1.

In vitro time-of-addition studies on anti-influenza virus activity of CLK1 inhibitors in MDCK cells by CPE reduction assay against H1N1.

Samples Name CC50 a CC0 b Pre-Treatment Assay Simultaneous Treatment Assay Post-Treatment Assay
μg/mL EC50 (μg/mL)c SI d EC50 (μg/mL) SI EC50 (μg/mL) SI
J10688 Clypearin >200 100 0.75 ± 0.13 >266.67 1.2 ± 0.28 >166.67 18.08 ± 3.02 >11.06
J12098 Corilagin 153.54 30 3.99 ± 3.72 38.48 2.00 ± 2.22 76.77 5.91 ± 1.44 25.98
J14848 Pinosylvin 18.26 10 7.54 ± 5.48 2.42 5.28 ± 2.45 3.46 6.65 ± 4.3 3.23
J12133 Chebulanin 90.27 30 15.29 ± 10.35 5.90 9.84 ± 0.44 9.17 21.11 ± 11.15 4.28
J25986 Propyl gallate 182.00 30 15.94 ± 6.94 11.42 12.88 ± 8.06 14.13 3.42 ± 0.2 53.22
J20353 Hispidulin 60.35 30 18.89 ± 5.1 3.19 5.26 ± 2.48 11.47 >30 ND
J21548 Norwogonin 91.79 30 >30 ND e >30 ND >30 ND
J11534 - 175.31 30 >30 ND e >30 ND >30 ND
J10610 Kaempferol 68.50 30 5.16 ± 2.4 13.28 12.34 ± 5.89 5.55 23.3 ± 1.08 2.94
J20725 Luteolin 24.86 10 >10 ND >10 ND 5.74 ± 0.54 4.33
J10857 - 77.72 30 18.43 ± 12.99 4.22 16.27 ± 2.29 4.78 14.67 ± 5.25 5.30
J14528 Isorhapontigenin 83.37 30 5.98 ± 2.3 13.94 >30 ND >30 ND
J14080 Epigallocatechin gallate 71.10 30 10.19 ± 6.22 6.98 14.86 ± 1.81 4.78 >30 ND
Methyl gallate Methyl gallate 69.50 30 >30 ND e >30 ND >30 ND
Genistein Genistein 75.60 30 >30 ND >30 ND >30 ND
Ribavirin Ribavirin >200 100 4.36 ± 0.99 >45.87 10.32 ± 2.38 >19.38 13.78 ± 3.47 >14.51
TG003 TG003 121.50 30 5.09 ± 0.78 23.87 15.75 ± 3.49 7.71 3.56 ± 1.47 34.13

a CC50: 50% cytotoxic concentration; b CC0: maximal non-cytotoxic concentration; c EC50: 50% effective concentration; d SI: selective index, CC50/EC50; e ND: not determined.